SCHEMBL7367829

SCHEMBL7367829

O=C(O)CCc1cc(-c2cnc3ccccc3n2)cc([N+](=O)[O-])c1CCC(=O)O

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.53
NPC1 O15118 6/20 0.47
RAB9A P51151 6/20 0.47
ALDH1A1 P00352 6/20 0.46
LMNA P02545 4/20 0.46
SMN1; SMN2 Q16637 4/20 0.46
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
HTT P42858 2/20 0.46
GAA P10253 1/20 0.45
KDM4E B2RXH2 1/20 0.45
HPGD P15428 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.45
NPSR1 Q6W5P4 1/20 0.43
FBP1 P09467 1/20 0.43
ADORA3 P0DMS8 1/20 0.40
RHOA P61586 1/20 0.40
MITF O75030 1/20 0.38
JAK3 P52333 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8726189 1.00 MAPT (0.53) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL7364700 0.78 MMP2 (0.48) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL7366879 0.73 MAPT (0.63) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL7371645 0.70 DAGLA (0.43) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL8731797 0.70 DAGLA (0.43) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL8726072 0.69 CETP (0.39) ALDH1A1LMNAKMT2AGAAKDM4E
SCHEMBL7374010 0.69 MAPT (0.66) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL7369543 0.69 KDM4E (0.44) MAPTNPC1RAB9AALDH1A1LMNA
SCHEMBL7364869 0.69 PRKAG1 (0.47) MAPTNPC1RAB9ALMNAFBP1
SCHEMBL7367777 0.69 MAPT (0.54) MAPTNPC1RAB9AALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5705703-A ENZYME INHIBITORS OF TRANSFERASES HOFFMANN-LA ROCHE INC. (US) 1998-01-06 US disclosed
US-5633371-A ENZYME INHIBITORS; TREATMENT OF DEPRESSION AND PARKINSON*S DISEASE HOFFMANN-LA ROCHE INC. (US) 1997-05-27 US disclosed
US-5476875-A Catechol derivatives HOFFMAN-LA ROCHE INC. (US) 1995-12-19 US disclosed
US-5389653-A Inhibitors of the enzyme catechol-O-methyltransferase; useful as co-medication in treatment of Parkinson's disease HOFFMAN-LA ROCHE INC. (US) 1995-02-14 US disclosed
US-5236952-A Inhibit the enzyme catechol-O-methyltransferase; for treatment of Parkinson's disease administered with L-dopa HOFFMANN-LA ROCHE INC. (US) 1993-08-17 US disclosed
EP-0237929-B1 3,5-DISUBSTITUTED PYROCATECHOL DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 1993-06-02 EP disclosed
EP-0237929-A1 3,5-Disubstituted pyrocatechol derivatives F. HOFFMANN-LA ROCHE AG (CH) 1987-09-23 EP disclosed